Pfizer Unveils Latest CoViD-19 Pill, The Paxlovid
We are now on the third year after the CoViD-19 starts
infecting a lot of people all over the world. All personnel from different
medical field have gathered and unite to try to create vaccines in a very short
period of time.
As of this writing, 3rd quarter of 2022,
according to World Health Organization, the list of available vaccines in the
market are as follows:
Pfizer-BioNTech COVID-19 vaccine
Moderna (mRNA-1273) COVID-19
vaccine
Oxford/AstraZeneca COVID-19 vaccine
J&J COVID-19 vaccine
Sinopharm COVID-19 vaccine
Sinovac COVID-19 vaccine
COVAXIN
Covovax
Novavax
CanSino Biologics Ad5-nCoV-S
[recombinant]
Pfizer's COVID-19 pill, Paxlovid, appears to have a lot of
positives, including an 89% reduction in the risk of hospitalization and death
in clinical trials.
Paxlovid is the latest COVID-19 treatment that’s been all
over the news. The drug was granted an emergency use authorization (EUA) by the
Food and Drug Administration (FDA) in December for anyone ages 12 and older who
weighs at least 88 pounds, and is at high risk for severe disease.
Paxlovid is an oral antiviral pill that can be taken at home
to help keep high-risk patients from getting so sick that they need to be
hospitalized. So, if you test positive for the coronavirus and you are eligible
to take the pills, you can take them at home and lower your risk of going to
the hospital.
The drug, developed by Pfizer, has a lot of positives: It had an 89% reduction in the risk of hospitalization and death in the clinical trial that supported the EUA, a number that was high enough to prompt the National Institutes of Health (NIH) to prioritize it over other COVID-19 treatments; and it’s cheaper than many other COVID-19 drugs (it’s provided for free by the U.S. government while there is a public health emergency); and, perhaps most reassuring, it is expected to work against the Omicron variant.
“I think it is the beginning of a ‘game-changer,’” says
Scott Roberts, MD, a Yale Medicine infectious diseases specialist. “It's really
our first efficacious oral antiviral pill for this virus. It shows clear
benefit, and it really can prevent hospitalization and death in people who are
at high risk.”
It’s important to note that Paxlovid (the brand name for the
drug, which is made up of two generic medications—nirmatrelvir and ritonavir)
isn’t the only pill available to treat COVID-19. The FDA also granted an EUA in
December to a pill from Merck called molnupiravir (Lagevrio), but some studies
suggest that molnupiravir has only a 30% reduction in the risk for
hospitalization and death from COVID-19.
And as far as convenience, this medication is considered an improvement over treatments like remdesivir (approved by the FDA in October 2020), which is administered by intravenous (IV) injection.
According to infectious diseases experts from Yale Medicine,
Paxlovid is an antiviral therapy that consists of two separate medications
packaged together. When you take your three-pill dose, two of those pills will
be nirmatrelvir, which inhibits a key enzyme that the COVID virus requires in
order to make functional virus particles. After nirmatrelvir treatment, the
COVID virus that is released from the cells is no longer able to enter
uninfected cells in the body, which, in turn, stops the infection. The other is
ritonavir, a drug that was once used to treat HIV/AIDS but is now used to boost
levels of antiviral medicines.
As a COVID-19 treatment, ritonavir essentially shuts down nirmatrelvir’s metabolism in the liver, so that it doesn’t move out of your body as quickly, which means it can work longer—giving it a boost to help fight the infection.
If you ask when you should take Paxlovid, you have to take
Paxlovid within five days of developing symptoms.
Like all antivirals, Paxlovid works best early in the course
of an illness—in this case, within the first five days of symptom onset, says
Jeffrey Topal, MD, a Yale Medicine infectious diseases specialist who is
involved in determining COVID-19 treatment protocols for Yale New Haven
Hospital patients.
“Once you’ve been ill with the virus for more than a week,
the damage done to the body in a severe case can’t be undone by the antiviral,”
he says.
The question now is, can anyone get a Paxlovid prescription?
The FDA authorized Paxlovid for people ages 12 and older who weigh at least 88
pounds. But in order to qualify for a prescription, you must also have had a
positive COVID-19 test result and be at high risk for developing severe
COVID-19.
That means you must either have certain underlying
conditions (including cancer, diabetes, obesity, or others) or be 65 or older
(more than 81% of COVID-19 deaths occur in in this group). The more underlying
medical conditions a person has, the higher their risk for developing a severe
case of COVID-19, according to the CDC.
The hope is that the restrictions on who can take Paxlovid will be relaxed over time. The FDA granted the EUA in December, just as a staggering number of people were infected with Omicron and the need for care skyrocketed, leading to supply issues.
If you are pregnant or breastfeeding, the FDA recommends
discussing your options and specific situation with your health care provider,
since there is no experience using the drug in these populations. If you could
become pregnant, it’s recommended that you use effective barrier contraception
or do not have sexual activity while taking Paxlovid.
It’s important to note that although health care providers
can write a prescription, pharmacists may also provide Paxlovid (with certain
limitations) if they’ve opted to do so, provided you can share your electronic
or printed medical records, including a list of medications you are already
taking, and blood test results from the last 12 months.
Paxlovid might be the latest advancement as far as battle
for CoViD-19 is concern, a lot of people are still having a lot of questions
about this Drug. We will try to update everyone about this. What’s more
important is, people’s lives are now going back to normal one day at a time.
Let’s hope and pray that this Virus will be eradicated for good as soon as
possible.
Cheerio!
Comments
Post a Comment